SLC9A3 and diabetes mellitus: Furthermore, these analogues have the ability to stimulate natriuresis by inhibiting sodium reabsorption by decreasing the activity of sodium-hydrogen exchanger 3 (NHE3), resulting in a reduction in blood pressure in patients with diabetes (40, 46).